951 results on '"Mizuno, Ryuichi"'
Search Results
2. Risk factors for postoperative fever after laparoscopic adrenalectomy focusing on hormones produced: a case control study
3. Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma
4. Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
5. Prognostic impact of tumor ureteral invasion on recurrence after radical cystectomy
6. Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy
7. Factors affecting the selection of eligible candidates for focal therapy for prostate cancer
8. Detection of the Highest-Grade Lesion in Multifocal Discordant Prostate Cancer by Multiparametric Magnetic Resonance Imaging
9. Impact of tumor contact surface area on collecting system entry in robot-assisted partial nephrectomy: a retrospective analysis
10. Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma
11. Strategy for PSA progression in patients undergoing salvage radiation for biochemical recurrence after radical prostatectomy
12. Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma
13. Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study
14. Current clinical perspective of urological oncology in the adolescent and young adult generation
15. ASO Visual Abstract: Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy
16. A low subcutaneous fat mass is a risk factor for the development of inguinal hernia after radical prostatectomy
17. Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma
18. Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab
19. Evaluation of prognostic factors and treatment options for renal angiosarcoma: A retrospective analysis of 113 reported cases
20. PD36-08 ARTIFICIAL INTELLIGENCE-BASED SURGICAL PHASE RECOGNITION IN ROBOT-ASSISTED RADICAL PROSTATECTOMY AND CROSS-SURGEON EXTERNAL VALIDITY VERIFICATION
21. PD20-09 THREE-DIMENSIONAL IMAGING AND SPATIAL ANALYSIS OF INTACT TISSUE IMPROVE DIAGNOSTIC YIELD AND ACCURACY IN UPPER TRACT UROTHELIAL CARCINOMA DIAGNOSIS
22. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
23. Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study
24. Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab
25. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases
26. Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma.
27. Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma
28. Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer
29. Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma
30. Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy
31. Impact of prostatic shape on the difficulty of robot‐assisted laparoscopic radical prostatectomy
32. Prevalence and management of proteinuria associated with vascular endothelial growth factor receptor‐targeted tyrosine kinase inhibitor treatment in advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer
33. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
34. Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer
35. Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy
36. On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma
37. Radiologic features of mixed epithelial and stromal tumors of the kidney: Hyperattenuating on unenhanced computed tomography and T2-hypointensity on magnetic resonance imaging
38. Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review
39. Malignancy-associated membranous nephropathy with PLA2R double-positive for glomeruli and carcinoma
40. Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy
41. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma
42. Can random bladder biopsies be eliminated after bacillus Calmette–Guérin therapy against carcinoma in situ?
43. Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching
44. The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm
45. MO25-2 Clinical outcomes of systemic therapy for metastatic renal cell carcinoma patients on hemodialysis
46. Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases
47. Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy
48. Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history
49. TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells
50. External validation of the "optimal PSA follow-up schedule after radical prostatectomy” in a new cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.